Abstract:OBJECTIVE: Rodent models have found that osteocalcin crosses the blood-brain barrier and regulates behaviour. No data are available on osteocalcin's effects on brain microstructure and cognitive performance in humans. We evaluated the association between serum osteocalcin concentrations and (i) brain microstructural changes on magnetic resonance imaging (MRI) and (ii) neuropsychological performance.DESIGN, PATIENTS AND MEASUREMENTS: We studied 24 consecutive obese subjects (13 women; age, 49·8 ± 8·1 years; body mass index [BMI], 43·9 ± 4·54 kg/m(2) ) and 20 healthy volunteers (10 women; age, 48·8 ± 9·5 years; BMI, 24·3 ± 3·54 kg/m(2) ) in a cross-sectional study within the multicentre FLORINASH Project. FLAIR signal intensity and DTI-metrics (primary (λ1 ), secondary (λ2 ) and tertiary (λ3 ) eigenvalues; fractional anisotropy (FA); and mean diffusivity) in the caudate, hypothalamus, thalamus and putamen, and in subcortical white matter were assessed. Cognitive performance evaluated by neuropsychological test battery.RESULTS: Lower osteocalcin concentrations were associated with BMI, higher λ1, λ2 and λ3 values at the caudate and lower FLAIR signal intensity at the caudate and putamen. Obese patients with lower osteocalcin concentrations had higher FA at putamen and thalamus. Lower osteocalcin concentrations were associated with higher Iowa Gambling Task (IGT) scores. FLAIR signal intensity at the caudate <601·832 yielded 85·7% sensitivity, 64·3% specificity, 70·6% negative predictive value and 81·8% positive predictive value for IGT score. Lower osteocalcin was an independent predictor of worse cognitive performance on multivariate analysis (F = 3·551, P = 0·01343; R(2) = 0·103). Bayesian information criterion demonstrated that osteocalcin had the predominant role in predicting IGT score.CONCLUSIONS: Lower serum osteocalcin concentrations are associated with brain microstructural changes and worse cognitive performance.

Osteocalcin in the brain: from embryonic development to age-related decline in cognition

Maternal and Offspring Pools of Osteocalcin Influence Brain Development and Functions

Osteocalcin, ovarian senescence, and brain health

Interaction of bone and brain: osteocalcin and cognition

Roles of osteocalcin in the central nervous system

Osteocalcin ameliorates cognitive dysfunctions in a mouse model of Alzheimer's Disease by reducing amyloid β burden and upregulating glycolysis in neuroglia

Lower serum osteocalcin concentrations are associated with brain microstructural changes and worse cognitive performance

Roles for osteocalcin in brain signalling: implications in cognition- and motor-related disorders

Osteocyte-derived Sclerostin Impairs Cognitive Function During Ageing and Alzheimer’s Disease Progression

Gut Microbiota Modulates Osteoclast Glutathione Synthesis and Mitochondrial Biogenesis in Mice Subjected to Ovariectomy

Osteocalcin improves glucose tolerance, insulin sensitivity and secretion in older male mice

Estrogen receptor beta in astrocytes modulates cognitive function in mid-age female mice

Differentially Expressed Genes in the Brain of Aging Mice With Cognitive Alteration and Depression- and Anxiety-Like Behaviors

Age-associated alteration of innate defensive response to a looming stimulus and brain functional connectivity pattern in mice

The Protective Effects of Osteocyte‐Derived Extracellular Vesicles Against Alzheimer's Disease Diminished with Aging

Alterations in Alzheimer's disease microglia transcriptome might be involved in bone pathophysiology

Ovocystatin Induced Changes in Expression of Alzheimer’s Disease Relevant Proteins in APP/PS1 Transgenic Mice

Impact of Aging on Copper Isotopic Composition in the Murine Brain

Age-associated transcriptomic and epigenetic alterations in mouse hippocampus

Novel Function of Osteocalcin in Chondrocyte Differentiation and Endochondral Ossification Revealed on a CRISPR/Cas9 bglap–bglap2 Deficiency Mouse Model

Osteocyte RANKL is required for cortical bone loss with age and is induced by senescence